ResMed (NYSE:RMD) Earns “Hold” Rating from Needham & Company LLC
Needham & Company LLC reiterated their hold rating on shares of ResMed (NYSE:RMD – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. A number of other analysts also recently issued reports on the company. Oppenheimer downgraded ResMed from an outperform rating to a market perform rating in a research note […]
More Stories
Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Recommendation of “Buy” from Brokerages
Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has been assigned a consensus rating of “Buy” from the eight research...
Lamine Yamal Net Worth: How Much Does Spain’s Youngest Footballer Earn?
A professional Spain’s youngest footballer, Lamine Yamal, is often known for his playing stints, and the impressive salary he earns....
Analysts Set Larimar Therapeutics, Inc. (NASDAQ:LRMR) PT at $20.00
Larimar Therapeutics, Inc. (NASDAQ:LRMR – Get Free Report) has been given a consensus rating of “Buy” by the nine ratings...
PennantPark Investment Co. (PNNT) to Issue Monthly Dividend of $0.08 on November 1st
PennantPark Investment Co. (NASDAQ:PNNT – Get Free Report) declared a monthly dividend on Wednesday, October 2nd, Wall Street Journal reports....
Global X SuperDividend REIT ETF (NASDAQ:SRET) to Issue Monthly Dividend of $0.16
Global X SuperDividend REIT ETF (NASDAQ:SRET – Get Free Report) declared a monthly dividend on Wednesday, October 2nd, NASDAQ reports....
Cohen & Steers Select Preferred and Income Fund, Inc. (PSF) to Issue Monthly Dividend of $0.13 on November 29th
Cohen & Steers Select Preferred and Income Fund, Inc. (NYSE:PSF – Get Free Report) announced a monthly dividend on Wednesday,...